{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:21:20Z","timestamp":1790767280525,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.cjca.2014.10.023","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T06:21:12Z","timestamp":1414045272000},"page":"407-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Adaptation and Remodelling of the Pulmonary Circulation in Pulmonary Hypertension"],"prefix":"10.1016","volume":"31","author":[{"given":"Myl\u00e8ne","family":"Vaillancourt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Ruffenach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolyane","family":"Meloche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2014.10.023_bib1","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0140-6736(03)13167-4","article-title":"Primary pulmonary hypertension","volume":"361","author":"Runo","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2014.10.023_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1750-1172-8-97","article-title":"Pulmonary arterial hypertension","volume":"8","author":"Montani","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cjca.2014.10.023_bib3","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1161\/CIRCULATIONAHA.113.006797","article-title":"Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertension","volume":"129","author":"Wojciak-Stothard","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.10.023_bib4","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1152\/ajplung.00031.2013","article-title":"The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models","volume":"305","author":"Dickinson","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cjca.2014.10.023_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","article-title":"Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension","volume":"115","author":"Rabinovitch","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2014.10.023_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1164\/rccm.201201-0164OC","article-title":"Modern age pathology of pulmonary arterial hypertension","volume":"186","author":"Stacher","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cjca.2014.10.023_bib7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1172\/JCI66843","article-title":"Linking endothelial dysfunction with endothelial cell activation","volume":"123","author":"Liao","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2014.10.023_bib8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cardiores.2005.08.002","article-title":"Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates","volume":"69","author":"Newby","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2014.10.023_bib9","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.drudis.2014.04.001","article-title":"Thrombosis, platelets, microparticles and PAH: more than a clot","volume":"19","author":"Lannan","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.cjca.2014.10.023_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pharmthera.2013.02.002","article-title":"Targeting the serotonin pathway for the treatment of pulmonary arterial hypertension","volume":"138","author":"Thomas","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cjca.2014.10.023_bib11","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1016\/j.febslet.2012.08.036","article-title":"Endothelin-1 induces hypoxia inducible factor 1\u03b1 expression in pulmonary artery smooth muscle cells","volume":"586","author":"Li","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cjca.2014.10.023_bib12","doi-asserted-by":"crossref","first-page":"C704","DOI":"10.1152\/ajpcell.00099.2013","article-title":"TRPV4 channel contributes to serotonin-induced pulmonary vasoconstriction and the enhanced vascular reactivity in chronic hypoxic pulmonary hypertension","volume":"305","author":"Xia","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.cjca.2014.10.023_bib13","doi-asserted-by":"crossref","first-page":"H1546","DOI":"10.1152\/ajpheart.00944.2011","article-title":"New mechanisms of pulmonary arterial hypertension: role of Ca2+ signaling","volume":"302","author":"Kuhr","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2014.10.023_bib14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1164\/rccm.201304-0686PP","article-title":"Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension","volume":"188","author":"Klinger","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cjca.2014.10.023_bib15","doi-asserted-by":"crossref","first-page":"L1082","DOI":"10.1152\/ajplung.00199.2009","article-title":"Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization","volume":"297","author":"Guignabert","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cjca.2014.10.023_bib16","doi-asserted-by":"crossref","first-page":"L361","DOI":"10.1152\/ajplung.00277.2013","article-title":"Endothelin-1 decreases endothelial PPAR\u03b3 signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension","volume":"306","author":"Wolf","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cjca.2014.10.023_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1164\/rccm.201402-0383OC","article-title":"Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension","volume":"190","author":"Potus","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cjca.2014.10.023_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1194\/jlr.M024398","article-title":"Activation of JNK\/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells","volume":"53","author":"Ma","year":"2012","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.cjca.2014.10.023_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ajpath.2011.03.040","article-title":"Plexiform lesions in pulmonary arterial hypertension","volume":"179","author":"Jonigk","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cjca.2014.10.023_bib20","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/CIRCULATIONAHA.109.927681","article-title":"Formation of plexiform lesions in experimental severe pulmonary arterial hypertension","volume":"121","author":"Abe","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.10.023_bib21","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1161\/CIRCULATIONAHA.114.008777","article-title":"Proteomic analysis implicates translationally controlled tumor protein as a novel mediator of occlusive vascular remodeling in pulmonary arterial hypertension","volume":"129","author":"Lavoie","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.10.023_bib22","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1165\/rcmb.2013-0349OC","article-title":"Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension","volume":"50","author":"Li","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.cjca.2014.10.023_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12016-011-8265-z","article-title":"The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension","volume":"44","author":"Kherbeck","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cjca.2014.10.023_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1165\/rcmb.2009-0365OC","article-title":"Perivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage","volume":"45","author":"Cuttica","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.cjca.2014.10.023_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1465-9921-9-20","article-title":"Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study","volume":"9","author":"Ulrich","year":"2008","journal-title":"Respir Res"},{"key":"10.1016\/j.cjca.2014.10.023_bib26","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.201202-0335OC","article-title":"Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension","volume":"186","author":"Savai","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cjca.2014.10.023_bib27","doi-asserted-by":"crossref","first-page":"200ra117","DOI":"10.1126\/scitranslmed.3006674","article-title":"Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension","volume":"5","author":"Tian","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cjca.2014.10.023_bib28","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1161\/CIRCULATIONAHA.110.978627","article-title":"Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension","volume":"123","author":"Vergadi","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.10.023_bib29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/CIRCRESAHA.115.304563","article-title":"Basigin mediates pulmonary hypertension by promoting inflammation and vascular smooth muscle cell proliferation","volume":"115","author":"Satoh","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2014.10.023_bib30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/jpi.12184","article-title":"Melatonin attenuates hypoxic pulmonary hypertension by inhibiting the inflammation and the proliferation of pulmonary arterial smooth muscle cells","volume":"57","author":"Jin","year":"2014","journal-title":"J\u00a0Pineal Res"},{"key":"10.1016\/j.cjca.2014.10.023_bib31","doi-asserted-by":"crossref","first-page":"e75415","DOI":"10.1371\/journal.pone.0075415","article-title":"Nuclear factor \u03ba-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension","volume":"8","author":"Price","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.cjca.2014.10.023_bib32","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1161\/CIRCULATIONAHA.113.007469","article-title":"Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension","volume":"129","author":"Ricard","year":"2014","journal-title":"Circulation"},{"issue":"6 suppl","key":"10.1016\/j.cjca.2014.10.023_bib33","doi-asserted-by":"crossref","first-page":"572S","DOI":"10.1378\/chest.128.6_suppl.572S-a","article-title":"Interleukin-6 causes mild pulmonary hypertension and augments hypoxia-induced pulmonary hypertension in mice","volume":"128","author":"Golembeski","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2014.10.023_bib34","doi-asserted-by":"crossref","first-page":"H1798","DOI":"10.1152\/ajpheart.00654.2011","article-title":"Dehydroepiandrosterone inhibits the Src\/STAT3 constitutive activation in pulmonary arterial hypertension","volume":"301","author":"Paulin","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2014.10.023_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1465-9921-12-128","article-title":"Kr\u00fcppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension","volume":"12","author":"Courboulin","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.cjca.2014.10.023_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2353\/ajpath.2008.070395","article-title":"Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension","volume":"172","author":"Lawrie","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cjca.2014.10.023_bib37","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00109-011-0762-2","article-title":"Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNF\u03b1 contributes to the pathogenesis of pulmonary arterial hypertension","volume":"89","author":"Sutendra","year":"2011","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.cjca.2014.10.023_bib38","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/HYPERTENSIONAHA.114.03791","article-title":"AAV delivery of tumor necrosis factor-\u03b1 short hairpin RNA attenuates cold-induced pulmonary hypertension and pulmonary arterial remodeling","volume":"64","author":"Crosswhite","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2014.10.023_bib39","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1183\/09031936.00104706","article-title":"Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension","volume":"29","author":"Perros","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjca.2014.10.023_bib40","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/2045-8932.114752","article-title":"Signal transduction in the development of pulmonary arterial hypertension","volume":"3","author":"Malenfant","year":"2013","journal-title":"Pulm Circ"},{"key":"10.1016\/j.cjca.2014.10.023_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2010.07.003","article-title":"Vascular remodeling in pulmonary arterial hypertension: multiple cancer-like pathways and possible treatment modalities","volume":"147","author":"Sakao","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2014.10.023_bib42","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00109-011-0788-5","article-title":"From oncoproteins\/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension","volume":"89","author":"Paulin","year":"2011","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.cjca.2014.10.023_bib43","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/CIRCRESAHA.109.197491","article-title":"Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3\u2013microRNA cluster 17\/92 pathway","volume":"104","author":"Brock","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2014.10.023_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/08941939.2013.873098","article-title":"Loss of suppressors of cytokine signaling 3 promotes aggressiveness in hepatocellular carcinoma","volume":"27","author":"Wu","year":"2014","journal-title":"J\u00a0Invest Surg"},{"key":"10.1016\/j.cjca.2014.10.023_bib45","doi-asserted-by":"crossref","first-page":"928315","DOI":"10.1155\/2013\/928315","article-title":"Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling","volume":"2013","author":"Chen","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.cjca.2014.10.023_bib46","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1172\/JCI24838","article-title":"Reversal of experimental pulmonary hypertension by PDGF inhibition","volume":"115","author":"Schermuly","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2014.10.023_bib47","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1183\/09031936.00181312","article-title":"Targeting cell motility in pulmonary arterial hypertension","volume":"43","author":"Paulin","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjca.2014.10.023_bib48","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.110.963314","article-title":"Signal transducers and activators of transcription-3\/Pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension","volume":"123","author":"Paulin","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.10.023_bib49","doi-asserted-by":"crossref","first-page":"L548","DOI":"10.1152\/ajplung.00428.2006","article-title":"Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension","volume":"293","author":"Masri","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cjca.2014.10.023_bib50","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1183\/09031936.00084211","article-title":"Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH","volume":"40","author":"Courboulin","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjca.2014.10.023_bib51","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20101812","article-title":"Role for miR-204 in human pulmonary arterial hypertension","volume":"208","author":"Courboulin","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cjca.2014.10.023_bib52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/2045-8932.109917","article-title":"Pim-1: a new biomarker in pulmonary arterial hypertension","volume":"3","author":"Renard","year":"2013","journal-title":"Pulm Circ"},{"key":"10.1016\/j.cjca.2014.10.023_bib53","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.112.000765","article-title":"Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study","volume":"127","author":"Hoeper","year":"2013","journal-title":"Circulation"},{"issue":"15 suppl","key":"10.1016\/j.cjca.2014.10.023_bib54","first-page":"6510","article-title":"Dasatinib or imatinib (IM) in newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): two-year follow-up from DASISION (abstract)","volume":"29","author":"Kantarjian","year":"2011","journal-title":"ASCO Meeting Abstracts"},{"key":"10.1016\/j.cjca.2014.10.023_bib55","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1056\/NEJMoa0912614","article-title":"Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia","volume":"362","author":"Saglio","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.10.023_bib56","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/CIRCULATIONAHA.113.006167","article-title":"Role for DNA damage signaling in pulmonary arterial hypertension","volume":"129","author":"Meloche","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.10.023_bib57","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/CIRCULATIONAHA.113.004136","article-title":"Heterogeneity in lung 18FDG uptake in pulmonary arterial hypertension potential of dynamic 18FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments","volume":"128","author":"Zhao","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.10.023_bib58","doi-asserted-by":"crossref","first-page":"88ra55","DOI":"10.1126\/scitranslmed.3002194","article-title":"The role of nogo and the mitochondria\u2013endoplasmic reticulum unit in pulmonary hypertension","volume":"3","author":"Sutendra","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cjca.2014.10.023_bib59","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cmet.2014.01.004","article-title":"The metabolic basis of pulmonary arterial hypertension","volume":"19","author":"Sutendra","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.cjca.2014.10.023_bib60","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1161\/CIRCULATIONAHA.109.916098","article-title":"Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension a basis for excessive cell proliferation and a new therapeutic target","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.10.023_bib61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.112.103176","article-title":"Histone deacetylation inhibition in pulmonary hypertension therapeutic potential of valproic acid and suberoylanilide hydroxamic acid","volume":"126","author":"Zhao","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.10.023_bib62","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.drudis.2014.05.015","article-title":"miRNAs in PAH: biomarker, therapeutic target or both?","volume":"19","author":"Meloche","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.cjca.2014.10.023_bib63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1086\/675980","article-title":"Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series)","volume":"4","author":"Potus","year":"2014","journal-title":"Pulm Circ"},{"key":"10.1016\/j.cjca.2014.10.023_bib64","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.healun.2012.03.010","article-title":"Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression","volume":"31","author":"Bockmeyer","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2014.10.023_bib65","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/CIRCULATIONAHA.111.060269","article-title":"MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach","volume":"125","author":"Parikh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.10.023_bib66","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1172\/JCI74773","article-title":"Systems-level regulation of microRNA networks by miR-130\/301 promotes pulmonary hypertension","volume":"124","author":"Bertero","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2014.10.023_bib67","first-page":"110","article-title":"PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice","volume":"119","author":"Kanda","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2014.10.023_bib68","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/CIRCRESAHA.112.267591","article-title":"A\u00a0role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples","volume":"111","author":"Caruso","year":"2012","journal-title":"Circ Res"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2014.10.023_bib69","doi-asserted-by":"crossref","first-page":"868.2","DOI":"10.1096\/fasebj.28.1_supplement.868.2","article-title":"Mir-126 dependent alteration of angiogenesis contributes to right ventricle failure in pulmonary arterial hypertension (868.2)","volume":"28","author":"Potus","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.cjca.2014.10.023_bib70","doi-asserted-by":"crossref","first-page":"L861","DOI":"10.1152\/ajplung.00201.2010","article-title":"MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration","volume":"299","author":"Sarkar","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cjca.2014.10.023_bib71","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/CIRCULATIONAHA.114.007405","article-title":"Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p","volume":"130","author":"Sharma","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.10.023_bib72","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nbt0713-577","article-title":"First microRNA mimic enters clinic","volume":"31","author":"Bouchie","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cjca.2014.10.023_bib73","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.10.023_bib74","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1161\/CIRCULATIONAHA.105.609008","article-title":"An abnormal mitochondrial\u2013hypoxia inducible factor-1\u03b1\u2013Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension","volume":"113","author":"Bonnet","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.10.023_bib75","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1172\/JCI333","article-title":"Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes","volume":"101","author":"Archer","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2014.10.023_bib76","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bcp.2014.07.011","article-title":"Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration","volume":"91","author":"Galletti","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cjca.2014.10.023_bib77","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201007-1106OC","article-title":"Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats","volume":"183","author":"Bogaard","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cjca.2014.10.023_bib78","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrg2521","article-title":"Long non-coding RNAs: insights into functions","volume":"10","author":"Mercer","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.cjca.2014.10.023_bib79","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1161\/CIRCRESAHA.114.303265","article-title":"Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth","volume":"114","author":"Michalik","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2014.10.023_bib80","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.114.011675","article-title":"LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis and atherosclerosis by enhancing p53 activity","volume":"130","author":"Wu","year":"2014","journal-title":"Circulation"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14014937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14014937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T08:32:48Z","timestamp":1717489968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X14014937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0828282X14014937"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2014.10.023","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adaptation and Remodelling of the Pulmonary Circulation in Pulmonary Hypertension","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2014.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}